Schizandrin A inhibits cellular phenotypes of breast cancer cells by repressing <scp>miR</scp>‐155

Abstract

Taken together, SchA downregulates miR-155 and results in the suppression of proliferation and motility in breast cancer cells. Our findings proposed that SchA might be used as an underlying therapeutic agent.